Cheap genome tests to predict future illness? Don't hold your breath

January 20, 2014 by Clara Gaff, The Conversation
Before the technology can used more widely, we need to ensure its use will bring improvements in health, quality and duration of life.Credit: shutterstock.com

Sydney's Garvan Institute is this week promoting its acquisition of an Illumina machine which it says can sequence the whole human genome for $1,000. The institute hopes genomic sequencing will become widely available in the near future, so Australians can understand and reduce their personal risk of certain diseases.

Genome sequencing is currently used to diagnose and treat some inherited disorders. But before the technology can be used more widely, we need to ensure its use will bring improvements in health, quality and duration of life.

Genome sequencing

The first human genome was sequenced 15 years ago at a cost of US$3 billion dollars and took over a decade to compete and assemble.

Sequencing an entire genome is a large task: if the human genome were a novel, sequencing it would be the equivalent to reading War and Peace one thousand times. The comprises approximately 25,000 pairs of genes that we each inherit from our parents. These provide the instruction code for all our bodily functions from the moment of conception.

Each of our individual genomes is different. There are about 3 million differences (variants) in the genomes of any two unrelated people. Many of these variants account for physical differences, such as eye colour, between individuals. Some influence the risk of diseases such as diabetes.

Rare variants that disrupt a gene's normal function (called mutations) may cause diseases that may be inherited. Knowing this information may help decision-making about management of disease or even enable individuals to reduce their disease risk by modifying diet and exercise, for example.

If applied on a wide scale, this technology could help reduce the burden of genetic disease in society.

Current use

In Australia, access to genetic testing has been limited largely to single gene tests for single genetic disorders. Only a handful of these tests are currently paid for through Medicare.

We are starting to see the introduction of gene panels that can screen for dozens or hundreds of high-risk genes in a single test. This is particularly useful for complex gene tests such as those used to identify patients with a high familial risk of developing cancer.

It is also possible to order gene tests from laboratories overseas that sequence the 1% of the genome that codes for the protein–coding genes (so called exome) or which can scan for many thousands of single risk variants. These tests are only available in Australia in a research setting but are likely to become routinely available to high-risk individuals and families in a year or so.

Genome sequencing is currently used to diagnose and treat some inherited disorders. Credit: shutterstock.com

Genome sequencing is currently used to diagnose and treat some inherited disorders. Image from shutterstock.com

Currently, this technology is being used to identify acquired mutations that arise in cancer cells to identify mutations for which there are specific therapies (so called targeted therapies). The aim here is to screen the patient's tumour for particular cancer mutations in order to match the right treatment to the right patient.

This personalised approach to medicine is being quickly embraced by oncologists and their patients.

But the true cost of performing this testing is higher than the base cost of $1,000 and includes the costs of timely sample processing, analysis, complex interpretation and reporting. These labour costs are presently unknown but could be several times the cost of the sequencing.

Death calculator? Not quite

Understandably, there is a lot of community interest in healthy people having their genomes sequenced to predict, and hopefully prevent, disease in the future.

But while we may be able to work out what an individual's genetic sequence is, we don't necessarily know what it means or know how to use the information. We are certainly a long way off being able to predict anyone's quality or duration of life.

One difficulty is that what causes a condition in one person may not affect another. For instance, one researcher points out that he carries a mutation known to cause a severe childhood condition, yet has no signs or symptoms of the condition.

Over time, large studies will build good evidence for the effects of variants associated with common conditions, as well as on the effect of prevention strategies based on this information.

In the meantime, ethical issues are arising over preventive testing. The United States' National Institute of Health recently announced funding to investigate the use of in screening of newborns.

As well as diagnosing conditions affecting these babies sooner, genomic sequencing could also predict the development of rare inherited adult onset conditions, such as hereditary breast cancer. This is information that some healthy, high-risk adults prefer not to know, while others may want to learn as much as possible.

There is currently no consistent view on how to deal with unexpected findings, which may or may not have health implications some time in the future, particularly when testing would be performed at birth or during pregnancy.

Genetic counselling, however, aims to facilitate decision-making based on personal values and accurate information, as well as promote adjustment after any results are received. This may help people considering testing to fully consider these complexities and their own preferences before undertaking any genetic testing.

Regulation

In Australia, laboratories offering genetic tests for medical use must be accredited to perform the particular tests. This helps ensure that all tests are both safe and effective and are performed only in an appropriate clinical context.

Government funding for such tests also requires the demonstration that the test and any associated treatments are cost effective.

These regulatory and funding requirements will present challenges for the new genomic technologies that are able to screen for all potential inherited disease risk in a given individual.

Much more research is needed to understand how best to use the vast amounts of information generated by these machines and to identify those individuals who will derive most benefit from or be harmed by this technology.

We also need to determine how to use genomic information cost effectively to improve quality of life and health outcomes.

Explore further: BROCA sequencing approach evaluates all 24 genes implicated in breast cancer

Related Stories

BROCA sequencing approach evaluates all 24 genes implicated in breast cancer

October 24, 2013
Since 1994, many thousands of women with breast cancer from families severely affected with the disease have been tested for inherited mutations in BRCA1 and BRCA2. The vast majority of those patients were told that their ...

Next-gen sequencing identifies genes associated with speech disorder

October 25, 2013
A collaborative team of researchers has used next generation sequencing to identify clinically relevant genetic variants associated with a rare pediatric speech disorder. The findings are published in the September 16, 2013 ...

Mutations in a gene that impacts immune function increase susceptibility to prostate cancer

August 29, 2013
A team of researchers led by Janet Stanford, Ph.D., of Fred Hutchinson Cancer Research Center has discovered that mutations in the gene BTNL2, which encodes a protein involved in regulating T-cell proliferation and cytokine ...

Next-generation genome screening is step toward precision cancer medicine for lung cancer

November 14, 2013
Precision cancer medicine has taken a strong step forward at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) with the addition ...

Deciphering the DNA of Alzheimer's patients

December 4, 2013
(HealthDay)—Data that details every gene in the DNA of 410 people with Alzheimer's disease can now be studied by researchers, the U.S. National Institutes of Health announced this week.

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.